A detailed history of E Rn Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, E Rn Financial, LLC holds 1,087 shares of ABBV stock, worth $195,660. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,087
Holding current value
$195,660
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $178,094 - $216,671
1,087 New
1,087 $214,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $795 - $989
6 Added 0.4%
1,511 $203,000
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $12,002 - $13,822
83 Added 5.84%
1,505 $239,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $196,676 - $235,867
1,422 New
1,422 $229,000
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $226,109 - $287,459
-1,643 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $216,843 - $269,041
1,643 New
1,643 $266,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track E Rn Financial, LLC Portfolio

Follow E Rn Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Rn Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on E Rn Financial, LLC with notifications on news.